findmyKOL
Clinical trialNCT05132829UnknownPhase 4Interventional

Azithromycin to Improve Latency in Exam Indicated Cerclage Control Trial

SponsorThomas Jefferson UniversityEnrollment50Anti-Bacterial AgentsAzithromycinCefazolinObstetric Labor ComplicationsObstetric Labor, PrematurePhysiological Effects of Drugs+3 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Azithromycin is an antibiotic that is effective against bacteria that been associated with preterm birth (PTB). The purpose of this study is to evaluate if the addition of azithromycin prior to exam indicated cerclage prolongs gestation. A cerclage is a suture placed in the cervix to prolong gestation.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Northwestern University

    Chicago, Illinois, United States

    Recruiting
  • Rutgers Robert Wood Johnson

    New Brunswick, New Jersey, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Azithromycin 1 gram IVCefazolin and indomethacin
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Dec 2021
Primary completion
31 Dec 2024
Completion
30 Jun 2025
Last update posted
26 Jun 2023
Registered enrollment
50
Registry id
NCT05132829
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.